Dr. Aude Segaliny, PhD

Senior Director, Head of Research & Early Development at Amberstone Biosciences

Speaker

Dr. Aude Segaliny has over 15 years of experience in immunology, cell biology, cytokine and receptor biology, microfluidic single-cell functional screening platform, and in vitro/in vivo characterization assays, with a focus on cancer therapeutics discovery. She is an accomplished scientist and R&D leader in cancer research and preclinical pharmacology. As a founding scientist of Amberstone Biosciences, Dr. Segaliny has played a pivotal role in advancing the company’s Tumor-Microenvironment Activated Therapeutics (T-MATE™) platform, successfully driving critical projects and achieving key milestones, including bringing lead candidates to the pre-IND stage. Known for her strong leadership, Dr. Segaliny fosters effective communication and collaboration between internal teams, external collaborators, advisors, and partners.